MediWound (MDWD) Cash from Investing Activities (2013 - 2025)
MediWound's (MDWD) quarterly Cash from Investing Activities came in at -$23.9 million in Q4 2025, down 594.84% year-on-year from $4.8 million in Q4 2024, and down 645.58% quarter-over-quarter from $4.4 million in Q3 2025.
MediWound (MDWD) Cash from Investing Activities (2013 - 2025) Analysis & Trends
MediWound's Cash from Investing Activities history runs 13 years deep, the most recent figure standing at -$23.9 million for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 594.84% year-over-year to -$23.9 million in Q4 2025; TTM through Dec 2025 was -$18.0 million, a 113.77% decrease from a year earlier, with the FY2025 full-year figure at -$18.0 million, down 113.77% from the prior year.
- Cash from Investing Activities slipped to -$23.9 million in Q4 2025 per MDWD's latest filing, from $4.4 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $5.0 million in Q4 2023 and bottomed at -$26.1 million in Q2 2023.
- The 5-year median for Cash from Investing Activities is -$160000.0 (2022), against an average of -$3.5 million.
- Across the five-year window, Cash from Investing Activities tumbled 8690.0% in 2022 and soared 130.65% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$116000.0 in 2021, then plunged by 2173.28% to -$2.6 million in 2022, then jumped by 290.67% to $5.0 million in 2023, then fell by 3.98% to $4.8 million in 2024, then sank by 594.84% to -$23.9 million in 2025.
- Per Business Quant, the three latest MDWD Cash from Investing Activities figures stand at -$23.9 million (Q4 2025), $4.4 million (Q3 2025), and $4.9 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 172.62 Mn |
| 10 | MediWound | 165.19 Mn | 160.39 Mn | 278,000.00 | -23.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23.89 Mn |
| Dec 31, 2025 | -23.89 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 4.91 Mn |
| Jun 30, 2025 | 4.91 Mn |
| Mar 31, 2025 | -3.34 Mn |
| Mar 31, 2025 | -3.34 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Sep 30, 2024 | -14.29 Mn |
| Sep 30, 2024 | -14.29 Mn |
| Jun 30, 2024 | 2.85 Mn |
| Jun 30, 2024 | 2.85 Mn |
| Mar 31, 2024 | -1.78 Mn |
| Mar 31, 2024 | -1.78 Mn |
| Dec 31, 2023 | 5.03 Mn |
| Dec 31, 2023 | 5.03 Mn |
| Sep 30, 2023 | -5.83 Mn |
| Sep 30, 2023 | -5.83 Mn |